OlsonLMNeiAMDierkhisingRAJoyceDLNeiSD. Warfarin-induced rapid rise in INR post-cardiac surgery is not associated with increased bleeding risk. Ann Pharmacother. 2019;53:1184-1191. doi:10.1177/1060028019858677
2.
BergmarkBAKamphuisenPWWiviottSD, et al. Comparison of events across bleeding scales in the ENGAGE AF-TIMI 48 trial. Circulation. 2019;140:1792-1801. doi:10.1161/CIRCULATIONAHA.119.041346
3.
GreiffGPleymHStensethRWahbaAVidemV. Genetic variation influences the risk of bleeding after cardiac surgery: novel associations and validation of previous findings. Acta Anaesthesiol Scand. 2015;59:796-806. doi:10.1111/aas.12504
4.
BergTMO’MearaJGOuNN, et al. Risk factors for excessive anticoagulation among hospitalized adults receiving warfarin therapy using a pharmacist-managed dosing protocol. Pharmacotherapy. 2013;33:1165-1174. doi:10.1002/phar.1280
5.
DanielsPRManningDMMoriartyJP, et al. Improving inpatient warfarin therapy safety using a pharmacist-managed protocol. BMJ Open Qual. 2018;7:e000290. doi:10.1136/bmjoq-2017-000290
6.
KamthornthanakarnIKrittayaphongR. Optimal INR level for warfarin therapy after mechanical mitral valve replacement. BMC Cardiovasc Disord. 2019;19:97. doi:10.1186/s12872-019-1078-3